Methodology

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
Methodology

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

The American Society of Clinical Oncology just published the new recommendations regarding VTE prophylaxis and treatment in patients with cancer

Read More
DOACs in the treatment of cancer-associated thrombosis
Methodology

DOACs in the treatment of cancer-associated thrombosis

Since the publication of the SELECT-D trial and the Hokusai-VTE Cancer study, there has been a shift in the treatment of cancer-associated thrombosis.

Read More
Bleeding complications and platelet dysfunction in patients with lymphoproliferative disease receiving Bruton tyrosine kinase inhibitors
Methodology

Bleeding complications and platelet dysfunction in patients with lymphoproliferative disease receiving Bruton tyrosine kinase inhibitors

Ibrutinib is an irreversible inhibitor of Bruton tyrosine kinase (Btk) that is approved for the treatment of chronic lymphocytic leukemia and indolent non-Hodgkin lymphomas...

Read More